The Outlook for Vaccines, Variants and Elusive Herd Immunity - Butler Financial, LTD
Quarterly Coordinates: Time Is On Our Side - April 17, 2023

Resources

The Outlook for Vaccines, Variants and Elusive Herd Immunity

How do COVID-19 vaccines perform against the delta variant? When is FDA approval expected? And is herd immunity really achievable?

Raymond James Biotechnology Analyst Steve Seedhouse, Ph.D., addresses these questions and more in the latest episode of For What It’s Worth. Hear him discuss the latest data around vaccine effectiveness, the transition from pandemic to possible endemic and how COVID-prompted innovation may open the door for the prevention of other illnesses.

  
Listen to For What It's Worth on Spotify

Recorded August 3, 2021.


Other posts you might like
ButlerFinancial
Why do the wealthy borrow? Sometimes, debt makes sense

Family & Lifestyle Strategic borrowing can keep your financial plan intact and at work. Truths that seem...

read more
ButlerFinancial
Recapping November’s key market events

Markets & Investing December 01, 2023 Review the latest Weekly Headings by CIO Larry Adam. Key...

read more
ButlerFinancial
When would it be ok to start cutting rates, and by how much?

Economy & Policy December 01, 2023 Chief Economist Eugenio J. Alemán discusses current economic...

read more